Cargando…

HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway

BACKGROUND: The human ether a-go-go-related gene 1 (HERG1) is involved in tumor progression; however, its role in esophageal squamous cell carcinoma (ESCC) is not well studied. This study investigated HERG1 function in ESCC progression and elucidated the underlying mechanisms. METHODS: The prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongqiang, Yang, Xuchun, Guo, Yan, Shui, Lin, Li, Shi, Bai, Yifeng, Liu, Yu, Zeng, Ming, Xia, Jianling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647263/ https://www.ncbi.nlm.nih.gov/pubmed/31331361 http://dx.doi.org/10.1186/s13046-019-1284-y

Ejemplares similares

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
por: Chan, Mikko C., et al.
Publicado: (2021)

ET-1 promotes the growth and metastasis of esophageal squamous cell carcinoma via activating PI3K/Akt pathway
por: Yin, Hui, et al.
Publicado: (2020)

The role and mechanism of TXNDC5 in diseases
por: Wang, Xueling, et al.
Publicado: (2022)

TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
por: Yuan, Kefei, et al.
Publicado: (2019)

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
por: Li, Bin, et al.
Publicado: (2017)

Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma
por: Fan, Zhiqin, et al.
Publicado: (2023)

TXNDC12 inhibits lipid peroxidation and ferroptosis
por: Tang, Lanlan, et al.
Publicado: (2023)

Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis
por: Wang, Lin, et al.
Publicado: (2013)

Txndc9 Is Required for Meiotic Maturation of Mouse Oocytes
por: Ma, Fanhua, et al.
Publicado: (2017)

Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway
por: Hu, Dong-Xin, et al.
Publicado: (2022)

HERG-like K(+) Channels in Microglia
por: Zhou, Wei, et al.
Publicado: (1998)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway
por: Qiao, Zhongshi, et al.
Publicado: (2022)

HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma
por: Zhang, Xueyuan, et al.
Publicado: (2022)

Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis
por: Chang, Xiaotian, et al.
Publicado: (2011)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
por: Jian, Jie, et al.
Publicado: (2020)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
por: Li, Bin, et al.
Publicado: (2014)

The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma
por: Wu, Ning, et al.
Publicado: (2018)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG
por: Wang, Jing, et al.
Publicado: (2022)

NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
por: Xu, Jia-cheng, et al.
Publicado: (2021)

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
por: Guo, Jida, et al.
Publicado: (2022)

TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway
por: Tang, Genxiong, et al.
Publicado: (2019)

Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway
por: Lu, Yunfei, et al.
Publicado: (2021)

Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence
por: Tan, Fengbo, et al.
Publicado: (2018)

Idiosyncratic Gating of HERG-like K(+) Channels in Microglia
por: Pennefather, Peter S., et al.
Publicado: (1998)

Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway
por: Shen, Zhipeng, et al.
Publicado: (2017)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
por: Luo, Qian, et al.
Publicado: (2022)

Silencing UHRF1 Enhances Radiosensitivity of Esophageal Squamous Cell Carcinoma by Inhibiting the PI3K/Akt/mTOR Signaling Pathway
por: Hui, Beina, et al.
Publicado: (2021)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
por: Wang, Mengmeng, et al.
Publicado: (2023)

The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways
por: Chiu, Wen-Chin, et al.
Publicado: (2016)

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
por: Zhang, Zhan‐Fei, et al.
Publicado: (2020)

Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
por: Shi, Ni, et al.
Publicado: (2019)

Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020)

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
por: Yang, Shuwen, et al.
Publicado: (2016)

CD147 promotes glucose metabolism, invasion and metastasis via PI3K/AKT pathway in oral squamous cell carcinomas
por: Huang, Yi, et al.
Publicado: (2019)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_akk0av49cdc0mi094cte8elh3s